Article PDF
Avoid common mistakes on your manuscript.
References
Roukos DH. Current status and future perspectives in gastric cancer management.Cancer Treat Rev 2000;26:243–55.
Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons.Ann Surg. 1993;218:583–92.
Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese gastric cancer congress.Gastric Cancer 1999;2:151–7.
Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.Cancer 2000;89:255–61.
Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric-cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients.Br J Cancer 2001;84:1602–9.
Bonnenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dissection for gastric cancer.N Engl J Med 1999;340:908–14.
Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical co-operation group.Br J Cancer 1999;79:1522–30.
Roukos DH, Kappas AM. Targeting extended lymph node dissection in gastric cancer.J Surg Oncol 2002;81:59–62.
Padera TP, Kadambi A, Di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics.Science 2002; 296:1883–6.
Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.Nat Med 2001;7:186–91.
Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease.Cancer Cell 2002;1:219–27.
Jain RK, Fenton BT. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction.J Natl Cancer Inst 2002;94:417–21.
Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer.Eur J Cancer 2001;37:918–23.
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma—2nd English Edition.Gastric Cancer 1998;1:10–24.
He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor-3 signaling.J Natl Cancer Inst 2002;94:819–25.
Jain RK, Padera PT. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy.J Natl Cancer Inst 2002; 94:785–7.
Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer.Gut 2001;48:225–9.
Nakajima T.Clinical practice guidelines for gastric cancer in Japan. Nishi Memorial Lecture. 4th International Gastric Cancer Congress. New York: 2001.
Martin RC 2nd, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.Ann Surg 2002;236:159–65.
Sun W, Haller DG. Recent advances in the treatment of gastric cancer.Drugs 2001;61:1545–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kappas, A.M., Roukos, D.H. Quality of surgery determinant for the outcome of patient with gastric cancer. Annals of Surgical Oncology 9, 828–830 (2002). https://doi.org/10.1007/BF02557517
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02557517